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important investigation to confirm prenatal diagnosis and
aids in future counselling. This study has the limitation that
autopsies could not be performed to confirm the diagnosis
after the termination of pregnancy. We recommend that
early ultrasound should be used to complement the 18-23
weeks scans as the natural history of certain abnormalities
does not allow early diagnosis.
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Abstract
Objective:

To investigate changes in total cholesterol, high density lipoprotein (HDL)-cholesterol, low density
lipoprotein (LDL)-cholesterol and triglycerides in serum of Pakistani patients with AMI due to age, gender, body
mass index (BMI), diabetes, hypertension, and smoking, and also find out the prevalence of
hypercholesterolemip, hypertriglyceridemia, "low HDL-cholesterol" and "isolated low-HDL cholesterol" in them.
Patients and Methods:
Serum samples from 451 consecutive AMI patients (250 from National Institute of
Cardiovascular Diseases, K4rachi and 201 from Armed Forces Institute of Cardiology, Rawalpindi) were
analyzed for total cholesterol, HDL-cholesterol and triglycerides using kit methods. LDL-cholesterol was
determined using the Friedewald formula.
Results:
Mean serum concentrations of total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides in
AMI patients were found to be 181 ± 50 mg/dl, 35.7 ± 11.3 mg/dl, 110 ± 47 mg/dl and 177 ± 127 mg/dl,
respectively. Mean levels of total cholesterol and HDL-cholesterol were not significantly affected by age, gender,
BMI, diabetes mellitus, hypertension and smoking. Mean LDL-cholesterol concentration, however, was found to
be significantly increased in diabetes mellitus (p=0.047), while age, gender, BMI, hypertension and smoking had
no significant effect on the levels of this lipoprotein. Mean levels of triglycerides were significantly decreased in
older patients (>50 years) compared to younger (<50 years) ones (p=0.019). Gender, BMI, diabetes mellitus,
hypertension and smoking, however, had no effect on triglyceride levels The frequencies of
hypercholesterolemia, hypertriglyceridemia, "low HDL-cholesterol" and "isolated low-HDL-cholesterol" were
found to be 30.6%, 30.1%, 48.6% and 34.1%, respectively.
Conclusion: High prevalence of hypertriglyceridemia and low HDL-cholesterol (which constitute a component
of metabolic syndrome) in Pakistani AMI patients is suggestive that these two lipid abnormalities could be playing
a major role in the development of atherosclerosis in Pakistani population (JPMA 54:544;2004).
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Introduction
Disorders in lipid metabolism (dyslipidemia) can
result in premature atherosclerosis', leading to the
development of cardiovascular disease (CVD).' It has
recently been pointed out that there is an epidemic of CVD
in urban South Asians.2 Pakistanis being part of this ethnic
group have very high rates of coronary artery disease
(CAD).3 According to official estimates CVD results in
more than 100,000 deaths every year4, however, the actual
figure may even be much higher than that. Several large
scale clinical trials have shown that lipid lowering
interventions are associated with reduced coronary events
and mortality.5 This shows the significance of determining
the lipid status of CAD patients in order to reduce any
further coronary events in them.
With the exception of a couple of reports, there is
hardly any published data on variability of lipid profile in
Pakistani patients with acute myocardial infarction (AMI).6
The present study was undertaken to investigate changes in
lipid profile in Pakistani patients with AMI due to age,
gender, body mass index (BMI), diabetes mellitus,
hypertension and smoking, and also find out the prevalence
of hypertriglyceridemia, low-HDL-cholesterol (both of
these constitute an important component of metabolic
syndrome), hypercholesterolemia and "isolated low-HDL
cholesterol" in a population from two tertiary care hospitals.

those with systolic blood pressure greater than 140 mmHg
and/or diastolic blood pressure of 90 mmHg or those on
regular anti-hypertensive medications were classified as
hypertensive. Those who were smoking cigarettes or "beeri'
regularly (one or more per day) were classified as smokers,
A body mass index of greater than 25 was classified as
overweight/obese.
Hypercholesterolemia: Serum cholesterol level >200
mg/d1.
Hypertriglyceridemia: Serum triglyceride level >200
mg/dl.
Low HDL-cholesterol: Serum HDL-cholesterol level <35
mg/d1.
Isolated low HDL-cholesterol: Serum HDL-cholesterol
level < 40 mg/dl and serum triglyceride level <150 mg/dl.
Five ml venous blood was collected from patients
within 24 hours of AMI and immediately transferred to
plain tubes. After clotting, the serum was separated by
centrifugation and stored frozen at -60°C until analysis.
Total cholesterol, high density lipoprotein (HDL)cholesterol and triglycerides were analyzed using
calorimetric kit methods (RANDOX, UK). The
concentration of low density lipoprotein (LDL)-cholesterol
was calculated using the Friedwald formula.
Mean values have been presented as means ±

Patients and Methods
A total of four hundred and fifty one consecutive
patients with AMI (age 30-75 years) admitted to the
National Institute of Cardiovascular Diseases (NICVD),
Karachi from January 2001 to June 2001 (n=250) and the
Armed Forces Institute of Cardiology, Rawalpindi from
August 2003 to September 2003 (n=201) were included in
this study. All of them had first acute attack of myocardial
infarction.
They had the confirmed diagnosis of AMI on the
basis of WHO criteria of clinical history suggestive of
myocardial ischaemia, ECG changes of myocardial damage
and elevation of biochemical markers (creatine kinase and
creatine kinase MB). All the patients were assessed for risk
factors such, as, diabetes mellitus, hypertension, BMI,
smoking etc. using the criteria given below. All those
patients who were pregnant, having malabsorption
syndrome, suffering from tuberculosis, liver disease,
uremia, cancer or using vitamin B-complex supplements
during the past 6 months were not included in this study.
The study was approved by the Ethical Review Committee
of the Aga Khan University.
Criteria for diabetes were set as an abnormal fasting
blood sugar level >125 mg/dl at admission, or having taken
hypoglycemic agents for already established diabetes. All
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Table 1. Demographic and clinical characteristics of AMI patients
(n=451).
Variable

Value

Frequency (%)

(mean ± SD)

Age (years)

54.3 ± 10.7

Gender
Male

341 (75.6)

Female

110 (24.4)

BMI (kg/m2)

25.0 ± 4.1

>25

189 (43.8)

Hypertensive Yes

243 (57.4)

No
Diabetic

180 (43.6)

Yes

153 (34.6)

No
Glucose (mg/dl)

289 (65.4)
137 ± 76

Cholesterol (mg/dl)

181

Triglycerides (mg/di)

177± 127

HDL-cholesterol (mg/dl)

35.7 ± 11.3

LDL-cholesterol (mg/di)

110±47

50
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standard deviation (SD). Univariate and multivariable
analyses were carried out using the SPSSt (statistical
package for social sciences) Software Version 10 for
Windows® to study the effect of various factors on lipid
levels. Independent sample t-test, chi-square test and
simple linear regression were used to test the significance at
the univariate level. Multiple linear regression was used to
test the significance at multivariable level. All variables
with p-value <0.2 were considered for multivariable
analysis. For comparison of lipid levels in younger and

older groups, the patients were divided into those above 50
years and those below 50 years. This cut off age of 50 years
was chosen to exclude the effect of female sex hormones on
lipid levels in older females, because the usual age of
menopause in female population is considered to be about
49 years. A p-value of <0.05 was considered significant.

Results
Table 1 shows the demographic and clinical
characteristics of patients. There were 341 males and 110

Table 2. Effect of age, gender, BMI, diabetes mellitus, hypertension
Factors

Numbera
Total cholesterol

and smoking on serum levels of lipids in AMI patients (mean ±SD).

Lipid concentration (mg/di)
HDL-cholesterol
LDL-cholesterol

Triglycerides

Age (years)
<50

171

187+52

>50

35.6+10_8

111+51

279

177+48

194+137

35.7+11.68

110+44

(p value 0.055)

166+109

(p value 0.911)

(p value 0.942)

(p value 0.019)*

174+124

Gender
Male

341.

179+48

35.3+11.2

Female

110

109+45

187+54

36.8+11.8

114+54

184+111

(p value 0.113)

(p value 0.253)

(p value0.324)

(p value 0.472)

BM1 (kg/m 2)
<25

243

177+48

>25

35.5+11.7

189

106+44

185+51

168+123

36.2+11.0

114+50

187+119

(p value 0.077)

(p value0.514)

(p value 0.082)

(p value 0.120)

Diabetes
Yes

153

186+51

No

34.2+9.8

116+49

289

177+49

183+111

36.3+12.2

106+45

(p value 0.082

175+128

(p value 0.089)

(p value 0.050)*

(p value 0.515)

175+120

Hypertension
Yes

243

179+47

No

35.2+11.7

109+47

180

181+52

36.3+11.2

108+46

(p value 0.695)

183+128

(p value 0.385)

(p value 0.748)

(p value 0.532)

Smokingb
Yes

123

184+53

No

34.2+11.2

203

111+49

181+48

176+111

35.0+10.3

113+46

(p value 0.639)

175+122

(p value 0.51)

(p value 0.723

(p value 0.906)

*Significant at p<0.05

a = Discrepancy in total number for certain factors (being less than 451) is due to some missing information.
b = Those who had quitted smoking or were occasional smokers were not included.
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females. Mean age of the group was 54.3 ± 10.7 years with
range 30-75 years. Mean BMI was 25 f 4.1 kg/m2. Mean
value of fasting serum glucose was 137 ± 76 mg/d1. Thirty
five percent of patients were diabetic, 57% were
hypertensive, while 43.8% were overweight/obese (BMI
>25). Mean values of serum total cholesterol, triglycerides,
HDL-cholesterol and LDL-cholesterol were 181 ± 50
mg/dl, 177 ± 127 mg/di, 35.7 ± 11.3 mg/dl, and 110 ± 47
mg/di, respectively.

"low HDL-cholesterol" and "isolated low HDL-cholesterol"
shown in Table 3. The frequencies of hypercholesterolemia,
hypertriglyceridemia, "low HDL-cholesterol" and "isolated
low HDL-cholesterol" were found to be 30.6%, 30.1 0/,
48.6% and 34.1%, respectively. A comparison of
percentages in the male and female groups using chi square
revealed statistically significant difference only in the low
HDL-cholesterol (p=0.04) group.

Table 3. Prevalence of hypercholesterolemia, hypertriglyceridemia, low HDL-cholesterol and isolated low HDL-cholesterol in AM1 patients.
Variable

Hypercholesterolemia

Frequency (%)
Males

Females

Total

(n=341)

(n=110)

(n=451)

98 (28.7)

40 (36.4)

138 (30.6)

0.13

99 (29)

37 (33.6)

136 (30.1)

0.36

174 (51)

45 (40.1)

219 (48.6)

0.04

121 (35.5)

33 (30)

154 (34.1)

0.29

(>200mg/dI)
Hypertriglyceridemia
(>200 mg/dl)
Low HDL-cholesterol
(<35 mg/dl)
Isolated low-HDLcholesterol(HDL<40 mg/dI

13-value*

and TG <150 mg/dl)

*P-value compares percentages in male and female groups and is based on test of association using chi square.

Table 2 shows the effect of age, gender, BMI,
diabetes mellitus, hypertension and smoking on serum
levels of total cholesterol, HDL-cholesterol, LDLcholesterol and triglycerides in AMI patients. Mean
concentrations of total cholesterol and HDL-cholesterol
were not significantly affected by age, gender, BMI,
diabetes mellitus, hypertension and smoking. Mean LDLcholesterol level, however, was found to be significantly
increased in diabetes mellitus (p=0.047), while age, gender,
BMI, hypertension and smoking had little effect on the level
of this lipoprotein. Mean levels of triglycerides were
significantly decreased in older patients (>50 years)
compared to younger (<50 years) ones (p=0.019). Gender,
BMI, diabetes, hypertension and smoking had no significant
effect on triglyceride levels in these patients. Multivariable
analysis of the data to see the combined effect of these
factors revealed no significant association between any of
these factors and the lipid levels in AMI patients.
Prevalence of hypercholesterolemia, hypertriglyceridemia,

Discussion
Pakistanis belong to an ethnic group which has the
highest rates of CAD.3 According to a recent estimate based
on scientific studies, nearly 100,000 individuals suffered an
AM1 in Pakistan in the calendar year 2002.7 Lehto et al.
have demonstrated direct correlations between the
incidence of AMI and plasma lipid abnormalities.8 There
are only few reports on lipid profile of Pakistani AMI
patients. A small study (n=31) carried out by Salahuddin et
al. revealed significantly high levels of triglycerides and
significantly low levels of HDL-cholesterol in AMI patients
compared to normal controls.6 This was suggestive of an
important role played by lipid abnormalities in the
development of atherosclerosis in our population. Our
results compare well with the baseline levels of lipids
reported in two other studies.5.6
The high levels of triglycerides in coronary heart
disease (CHD) have also been reported among Indians by
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Gupta et al.9 and among Egyptians by Metwalli et al.10 The
increased levels of triglycerides in Pakistani, Indian and
Egyptian AMI patients could be due to their genetic makeup
and nutritional habits involving high consumption of
saturated fats.11,12

state and a prothrombotic state poses a significant health risk
to individuals and is a growing health crisis for our country.
Our dietary habits could have contributed to this
atherogenic dyslipidemia in AMI patients. Decreased serum
HDL-cholesterol is considered to be one of the most
common lipid disorders in AMI patients.8 The mechanisms
responsible for this change may reside in the decreased
synthesis and secretion of HDL-cholesterol from liver
and/or accelerated elimination from the blood stream by
extravasation. Increased permeability of the capillary
membranes during the acute inflammation after AMI has
been shown to cause extravasation of HDL-cholestero1.21 A
focus on the strategies to decrease triglyceride levels and
increase HDL-cholesterol levels in CAD patients, such as
cessation of smoking13 and use of low-fat diet which is high
in polyunsaturated fatty acids22,23 decreased consumption of
ghee (which has high proportion of saturated fars and trans
fatty acids)24, will greatly help in reducing future coronary
events in them.

Our results show that hypertension has no effect on
lipid levels in our patients (Table 2). This is suggestive that
the factors leading to hypertension have little effect on the
lipid profile in AMI patients. Similarly, diabetes mellitus
also appears to have no significant effect on levels of total
cholesterol, HDL-cholesterol and triglycerides in AMI
patients. There was, however, an increase in LDLcholesterol. Although, smoking is known to affect serum
lipid levels, especially a decrease in the HDLcholestero113,14 yet in the present study it did not appear to
have any significant impact on lipid profile in AMI patients.
This lack of association observed by us could have been due
to the absence of information regarding the frequ'ency and
duration (number of years) of smoking by the patients.
Thirty one percent of our patients had
hypercholesterolemia (Table 3). This frequency compares
well with 37% reported by Ishaq et al. in a recent study.15 It
is noteworthy that the baseline mean HDL-cholesterol
levels in our patient population are well below the normal
levels (40 mg/di) recommended by the National Cholesterol
Education Program16, indicating that low levels of HDLcholesterol in our AMI patients may have contributed to
their accelerated coronary atherosclerosis resulting into
AMI.
In fact, the prevalence of "low HDL-cholesterol"
(<35 mg/dl) in our population of patients (48.6%) was
among the highest in the world (Table 3) as compared to
other studies done internationally.9,17-19
Similarly the prevalence of "isolated low-HDLcholesterol" (HDL <40 mg/dl and triglycerides <150 mg/dl)
in our AMI patients was found to be 34.1% (Table 3) which
is very high compared to. its frequency in other
populations.17
Hypertriglyceridemia appears to be a prominent
feature in CHD. In our study, its prevalence in AMI patients
was found to be 30% which is higher as compared to a study
in a Caucasian population of CAD patients in Boston.19
In conclusion, our data confirms the previous
observations that high levels of triglycerides and low levels
of HDL-cholesterol are the most prominent lipid
abnormalities in Pakistani AMI patients. These two lipids
abnormalities constitute an important component of
"metabolic syndrome" known as "atherogenic
dyslipidemia".20 This syndrome, which in addition to
atherogenic dyslipidemia, also includes abdominal obesity,
elevated blood pressure, insulin resistance, a proinflammatory
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Abstract
Objective: To assess the onset and duration of benefit of counselling by minimally trained community
counsellors on level of anxiety and/or depression in women of their own community.
Method: A randomized controlled trial for assessing the effectiveness of 4 and 8 weeks of counselling by
minimally trained community women in reducing the levels of anxiety and depression was carried out in a lower
middle class, semi-urban community in Karachi, Pakistan. In the baseline survey, 366 anxious and/or depressed
women were identified and randomized to intervention and control arms. The intervention arm was re-screened
for anxiety and depression after 4 and 8 weeks of counselling and again 8 weeks after the last counselling
session. As the results showed a significant benefit in the intervention arm, for ethical reasons the controls were
also counselled; and were screened in the same way. This study is a sub-analysis from the RCT specifically
looking at the onset and the duration of benefit.
Results: A significant reduction in the mean scores of both the groups was found after 4 weeks of counselling
which further improved at 8 weeks. The gradient of improvement was steeper at 4 weeks. At 8 weeks post
counselling some loss of effect was detected but the levels still remained below the initial mean score.
Conclusion:. This study indicates that literate women from semi urban communities can be trained as
counsellors and their counselling can lead to a significant benefit in just 4 counselling sessions of 1 hour each,
and could last at least till 8 weeks after the last session. Keeping in view the current high prevalence, the
available facilities for treatment and the stigma attached to psychiatric treatment in our communities; this
modality of intervention at the PHC level could be an alternative strategy for the management of depression
(JPMA 54:549;2004).

Introduction
Counselling and psychotherapy have evolved as

forms of interventions for anxiety and depression.1,2 Brief
psychotherapy or cognitive behavior therapy is being widely
used in general practice, and patients referred to counsellors
have shown a statistically significant improvement
compared to those receiving treatment from general
practitioners only.3.4 Controlled trials have shown that
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cognitive behavioral therapy and interpersonal
psychotherapy have achieved results comparable to
antidepressants5-1 and the delay in the onset of benefit is the
same for both interventions.8 Several attempts have been
made to assess the persistence of the gains after different
intervals of having stopped psychotherapy/counselling.9-12
A relapse rate after 1 year of stopping pharmacotherapy is
being reported as 80% and that after cognitive behaviour
therapy is saidto be 25%. It is being said that these findings
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